Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7323466
APP PUB NO 20060178510A1
SERIAL NO

11332103

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention refers to chemical compounds of formula (I) ##STR00001## as well as pharmaceutically acceptable salts and esters thereof, wherein R.sup.1 to R.sup.5 have the significance given in claim 1. These compounds can be used for the preparation of medicaments.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HOFFMANN-LA ROCHE INC340 KINGSLAND STREET NUTLEY NJ 07110

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bentley, Jonathan Mark Wokingham, GB 24 100
Dawson, Claire Elizabeth Wokingham, GB 13 94
Guba, Wolfgang Muellheim, DE 70 314
Hebeisen, Paul Basel, CH 57 211
Monck, Nathaniel Wokingham, GB 2 0
Pratt, Robert Mark Wokingham, GB 11 28
Richter, Hans Grenzach-Wyhlen, DE 116 703
Roever, Stephan Inzlingen, DE 75 314
Ruston, Vicki Wokingham, GB 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation